Microfluidics in Biomaterial Development: Revolutionizing Drug Discovery
*Corresponding Author: Shahmabadi Alavi, Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Iran, Email: Shahmabadialavi@gmail.comReceived Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Citation: Shahmabadi A (2024) Microfluidics in Biomaterial Development:Revolutionizing Drug Discovery. J Biotechnol Biomater, 14: 410.
Copyright: © 2024 Shahmabadi A. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Abstract
Microfluidics has emerged as a transformative technology in biomaterial development, significantly impacting drug discovery processes. By enabling precise control over fluid flow at the microscale, microfluidics facilitates the creation of biomaterials with tailored properties, enhancing drug formulation and delivery. This review explores the integration of microfluidic systems in the design and fabrication of biomaterials, highlighting their applications in high-throughput screening, personalized medicine, and in vitro models. Additionally, we discuss the advantages of microfluidic platforms in reducing material waste, improving reproducibility, and accelerating the development timeline for new therapeutics. The convergence of microfluidics and biomaterials represents a paradigm shift in the drug discovery landscape, offering innovative solutions to longstanding challenges in the pharmaceutical industry.
